Average Co-Inventor Count = 6.14
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nerviano Medical Sciences S.r.l. (27 from 138 patents)
2. Farmitalia Carlo Erba S.r.l. (7 from 140 patents)
3. Pfizer Italia S.r.l. (6 from 23 patents)
4. Pharmacia & Upjohn S.p.a. (3 from 97 patents)
5. Pharmacia Italia S.p.a. (2 from 26 patents)
6. Pharmacia S.p.a. (2 from 20 patents)
7. Other (1 from 832,680 patents)
8. Pharmacia Corporation (1 from 200 patents)
49 patents:
1. 10479779 - Substituted pyrroles active as kinases inhibitors
2. 10479778 - Substituted pyrroles active as kinases inhibitors
3. 10280176 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
4. 10071986 - Substituted pyrroles active as kinases inhibitors
5. 9688661 - Substituted pyrroles active as kinases inhibitors
6. 9637497 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
7. 9464090 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
8. 9309253 - Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
9. 9284298 - Pyrazolyl-pyrimidine derivatives as kinase inhibitors
10. 9283224 - Substituted pyrimidinyl-pyrroles active as kinase inhibitors
11. 8993556 - Resorcinol derivatives as HSP90 inhibitors
12. 8981089 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
13. 8975267 - Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
14. 8912200 - Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
15. 8785448 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors